Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Split-dose Pico-Salax versus PEG bowel preparation in hospitalized patients undergoing colonoscopy
MOH_2024-02-11_013252Phase 4Not yet recruiting
- Sponsor
- ד"ר מעין איתן
- Start
- Jan 2024
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial comparing PEG bowel preparation with Pico-Salax bowel preparation (2 arms). Primary endpoint: Bowel preparation adequacy at colonoscopy. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
sodium picosulfate + magnesium oxide + citric acidmacrogol
Beyond the preview
Go deeper on MOH_2024-02-11_013252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2024-02-11_013252.